IFIH1 and systemic lupus erythematosus: Anti-MDA5 antibody, which is the centerpiece of the MDA5+ DM, has been found to be present positive but low-grade in some other diseases, such as systemic lupus erythematosus (SLE) and COVID-19 (17, 31).